Yang Fan, Lian Qinghai, Ni Beibei, Qiu Xiusheng, He Yizhan, Zou Xiaoguang, He Fangping, Chen Wenjie
Biotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Department of Infectious Diseases, The First People's Hospital of Kashi, Kashi, Xinjiang, China.
Liver Res. 2022 Dec 9;6(4):258-268. doi: 10.1016/j.livres.2022.12.002. eCollection 2022 Dec.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. The development of biomarkers for early detection and monitoring of HCC has not shown significant progress. Meanwhile, the second adenomatous polyposis-related gene, MUTYH, which encodes a DNA glycosylase, has been observed in its contribution to oxidative DNA damage repair. Abnormal expression of MUTYH can reduce cell survival rate. Therefore, this study investigated the usefulness of MUTYH in diagnosing and prognosis HCC.
Using The Cancer Genome Atlas (TCGA) data, we analyzed the prognostic value of MUTYH in HCC. We used logistic regression, Wilcoxon signed-rank test, and Kruskal-Wallis test to examine MUTYH expression concerning clinical-pathologic characteristics. Univariate and multivariate Cox regression methods and Kaplan-Meier analysis were applied to determine the related prognostic factors of HCC. The enrichment analysis (GSEA) was used to determine the critical pathways associated with MUTYH. The single-sample gene set enrichment analysis (ssGSEA) was conducted to examine the correlation between MUTYH expression and cancer immune infiltration.
The higher expression of MUTYH in HCC patients was associated with a poorer overall survival rate and a shorter disease-specific survival rate. The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that all differentially expressed genes (DEGs) between the high and low expression levels of MUTYH significantly enriched in the trace ligand-receptor interaction, cell cycle, oocyte meiosis, gap junction, and DNA replication. Group analysis revealed the signals of their open access. The neuron system, M phase, DNA repair, Rho GTPase effector, and cell cycle checkpoints were significantly enriched. ssGSEA showed a positive correlation between MUTYH expression and the infiltration levels of Th2 cells, NK cells, and T helper cells. Moreover, a negative correlation was found between MUTYH expression and the infiltration levels of dendritic cells (DCs) and cytotoxic cells.
MUTYH expression levels were positively correlated with immune checkpoint gene expression levels in HCC tissues. The expression level of MUTYH was related to the prognosis of HCC and the immune infiltration of HCC.
肝细胞癌(HCC)是全球癌症相关死亡的主要原因。用于早期检测和监测HCC的生物标志物的开发尚未取得显著进展。同时,已观察到第二个腺瘤性息肉病相关基因MUTYH(其编码一种DNA糖基化酶)在氧化DNA损伤修复中发挥作用。MUTYH的异常表达会降低细胞存活率。因此,本研究探讨了MUTYH在HCC诊断和预后中的作用。
利用癌症基因组图谱(TCGA)数据,我们分析了MUTYH在HCC中的预后价值。我们使用逻辑回归、Wilcoxon符号秩检验和Kruskal-Wallis检验来研究MUTYH表达与临床病理特征的关系。采用单因素和多因素Cox回归方法以及Kaplan-Meier分析来确定HCC的相关预后因素。富集分析(GSEA)用于确定与MUTYH相关的关键途径。进行单样本基因集富集分析(ssGSEA)以研究MUTYH表达与癌症免疫浸润之间的相关性。
HCC患者中MUTYH的高表达与较差的总生存率和较短的疾病特异性生存率相关。京都基因与基因组百科全书(KEGG)分析表明,MUTYH高表达水平和低表达水平之间的所有差异表达基因(DEG)在痕量配体-受体相互作用、细胞周期、卵母细胞减数分裂、间隙连接和DNA复制中显著富集。分组分析揭示了它们的开放获取信号。神经系统、M期、DNA修复、Rho GTPase效应器和细胞周期检查点显著富集。ssGSEA显示MUTYH表达与Th2细胞、NK细胞和辅助性T细胞的浸润水平呈正相关。此外,发现MUTYH表达与树突状细胞(DC)和细胞毒性细胞的浸润水平呈负相关。
HCC组织中MUTYH表达水平与免疫检查点基因表达水平呈正相关。MUTYH的表达水平与HCC的预后及HCC的免疫浸润有关。